S'abonner

Blood loss after revision knee arthroplasty is 1.38- to 2.17-fold higher than after primary knee arthroplasty: A retrospective analysis of 898 cases - 27/04/21

Doi : 10.1016/j.otsr.2021.102856 
Antonio Klasan a, b, , Florian Gerber b, Arne Schermuksnies b, Sven Edward Putnis c, Thomas Neri d, e, Thomas Jan Heyse f
a North Shore hospital, Auckland, New Zealand 
b University hospital of Marburg, Marburg, Germany 
c Avon orthopaedic centre, Southmead hospital, Bristol, United Kingdom 
d Department of orthopaedic surgery, University hospital centre of Saint-Étienne, Saint-Étienne, France 
e EA 7424 – Inter-university laboratory of human movement science, University of Lyon – University Jean-Monnet, Saint-Étienne, France 
f Orthomedic Offenbach, Frankfurt, Germany 

*Corresponding author at: North Shore hospital, 445, Victoria avenue, 2067 Chatswood, New Zealand.North Shore hospital445, Victoria avenueChatswood2067New Zealand

Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.

Connectez-vous pour en bénéficier!

Abstract

Background

There are a number of factors that influence blood loss during and after primary total knee arthroplasty (TKA) and revision TKA (rTKA). The purpose of this study was to provide a factorial assessment that would aid surgeons in managing expected blood loss in rTKA, when compared to TKA. The first question asked was the blood loss and transfusions between TKA and rTKA and the second question was risk factors for blood loss after rTKA.

Hypothesis

Blood loss in any rTKA is higher than in TKA by a factor of 2.

Patients and methods

A retrospective single-centre consecutive series of rTKA between 2006 and 2018 was performed. Based on the rTKA types identified in joint registries, 4 rTKA cohorts were created: aseptic minor rTKA, aseptic major rTKA, 1st stage, and 2nd stage septic rTKA. A consecutive TKA cohort from the same study period was used to create a propensity score matched cohort with the aseptic major rTKA cohort.

Result

A total of 622 rTKA were identified. Aseptic major rTKA had double the median blood loss than TKA. The lowest blood loss was observed in the TKA group followed by aseptic minor rTKA, and the highest in 2nd stage septic rTKA. The median total blood loss was higher in all rTKA by a factor ranging between 1.38 and 2.17. Higher age, female gender, lower preoperative hemoglobin, chronic heart disease and history of myocardial infarction were risk factors for increased blood loss. The type of rTKA performed was not predictive of blood loss in the linear regression analysis.

Discussion

Blood loss after rTKA is 1.38 to 2.17-fold higher than after TKA. The blood loss observed in 2nd stage septic rTKA and aseptic major rTKA was the highest. Older female patients, with a low preoperative hemoglobin, were identified to be at the highest risk of blood loss after rTKA. Strategies for further blood loss reductions need to be utilised to the fullest extent for these procedures.

Level of evidence

III; retrospective prognostic study.

Le texte complet de cet article est disponible en PDF.

Keywords : Total knee arthroplasty, Revision knee arthroplasty, Blood loss, Septic TKA revision, Tranexamic acid


Plan


 This work was performed at the University Hospital Marburg, Centre for Orthopedics and Traumatology, Marburg, Germany.


© 2021  The Author(s). Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 107 - N° 3

Article 102856- mai 2021 Retour au numéro
Article précédent Article précédent
  • Oral administration of prednisone effectively reduces subacute pain after total knee arthroplasty
  • Xingwang Cheng, Zhibing Wang, Yuan Zhang, Xia Zhang
| Article suivant Article suivant
  • Is serum gentamicin concentration modified with autologous cell-saved blood transfusion after total knee arthroplasty using tranexamic acid? A randomised control trial
  • Panagiotis Touzopoulos, Konstantinos Arvanitidis, Eirini Filidou, Konstantinos Tilkeridis, Michael Karanikas, George Kolios, Athanasios Ververidis

Bienvenue sur EM-consulte, la référence des professionnels de santé.

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2025 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.